A nationwide study confirms GLP-1 RAs pose no short-term psychiatric risk, showing a negative association with suicidal ...

As India steps into 2025, breakthrough weight-loss drugs, economic shifts, and global trends shape the road to a Viksit ...

The DPP-4 inhibitors represent the first oral therapies ... extending the physiologic half-life of endogenous GLP-1 and GIP by preventing their degradation. These agents are entirely dependent ...

Clarivate Plc (NYSE:CLVT) a leading global provider of transformative intelligence, today announced the release of the ...

GLP-1 is progressively deficient in people with impaired glucose tolerance and Type 2 diabetes ... Potential risks associated with DPP-4 inhibitors include the prolongation of the action of ...

A new study finds semaglutide is linked to an increased risk of vision loss associated with a rare eye condition, but cases remain rare. Here's what experts want you to know.

More than two billion people worldwide live with overweight or obesity, conditions closely linked to an array of health ...

For Robert F. Kennedy Jr., the activist whom President-elect Donald Trump will nominate to serve as the secretary of health and human services, the solution to obesity in America – now at 40% of ...

Failed to fetch dynamically imported module: https://finance.yahoo.com/assets/_app/immutable/nodes/97.B9uuF-Zi.js ...

Scholar Rock (NASDAQ: SRRK), a late-stage biopharmaceutical company focused on advancing innovative treatments for spinal ...

President-elect Donald Trump has chosen two prominent men to lead health-related affairs in his administration, Mehmet Oz, MD, and Robert Kennedy, Jr. While the two leaders will be leading health ...